These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22337711)

  • 41. Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children.
    Lee ES; Kronsberg H; Findling RL
    Child Adolesc Psychiatr Clin N Am; 2020 Jan; 29(1):183-210. PubMed ID: 31708047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia.
    Emsley R; Asmal L; Rubio JM; Correll CU; Kane JM
    Schizophr Res; 2020 Nov; 225():55-62. PubMed ID: 31767510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabidiol as a potential treatment for psychosis.
    Schubart CD; Sommer IE; Fusar-Poli P; de Witte L; Kahn RS; Boks MP
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):51-64. PubMed ID: 24309088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
    Di Capite S; Upthegrove R; Mallikarjun P
    Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rationale and parameters for medication-free research in psychosis.
    McGlashan TH
    Schizophr Bull; 2006 Apr; 32(2):300-2. PubMed ID: 16461574
    [No Abstract]   [Full Text] [Related]  

  • 46. Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic.
    Hetrick S; Alvarez-Jiménez M; Parker A; Hughes F; Willet M; Morley K; Fraser R; McGorry PD; Thompson A
    Australas Psychiatry; 2010 Oct; 18(5):451-5. PubMed ID: 20863186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review.
    Moncrieff J; Crellin NE; Long MA; Cooper RE; Stockmann T
    Schizophr Res; 2020 Nov; 225():47-54. PubMed ID: 31604607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications for future research of "medication-free research in early episode schizophrenia".
    Schooler NR
    Schizophr Bull; 2006 Apr; 32(2):297-8. PubMed ID: 16481657
    [No Abstract]   [Full Text] [Related]  

  • 49. Medication strategies in first episode psychosis patients: A survey among psychiatrists.
    Kikkert MJ; Veling W; de Haan L; Begemann MJH; de Koning M; ; Sommer IE
    Early Interv Psychiatry; 2022 Feb; 16(2):139-146. PubMed ID: 33754470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CE: Antipsychotic Medications.
    Sabella D
    Am J Nurs; 2017 Jun; 117(6):36-43. PubMed ID: 28504976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early predictors for late hospitalizations up to 14 years after first episode psychosis.
    Strålin P; Skott M; Cullberg J
    Soc Psychiatry Psychiatr Epidemiol; 2021 Aug; 56(8):1371-1380. PubMed ID: 33263822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.
    Upthegrove R; Manzanares-Teson N; Barnes NM
    Schizophr Res; 2014 May; 155(1-3):101-8. PubMed ID: 24704219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medication discontinuation in first episode psychosis: thinking about the offset of psychotic disorders.
    Galletly C; Suetani S; Dark F
    Aust N Z J Psychiatry; 2018 Sep; 52(9):819-821. PubMed ID: 30058834
    [No Abstract]   [Full Text] [Related]  

  • 54. Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis.
    Hayes JF; Osborn DP; Lundin A; Dalman C
    J Psychopharmacol; 2019 Apr; 33(4):532-534. PubMed ID: 30777499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early intervention for psychosis: who refers?
    Addington J; Addington D
    Schizophr Res; 2006 May; 84(1):176-7. PubMed ID: 16546354
    [No Abstract]   [Full Text] [Related]  

  • 56. Who needs antipsychotic maintenance treatment and who does not? Our need to profile and personalize the treatment of first episode psychosis.
    Wunderink L
    Schizophr Res; 2018 Jul; 197():65-66. PubMed ID: 29128323
    [No Abstract]   [Full Text] [Related]  

  • 57. Is the Evidence Strong Enough to Warrant Long-Term Antipsychotic Use in Compulsory Outpatient Treatment?
    Barnes SS; Badre N
    Psychiatr Serv; 2016 Jul; 67(7):784-6. PubMed ID: 26975525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
    Winton-Brown TT; Elanjithara T; Power P; Coentre R; Blanco-Polaina P; McGuire P
    Schizophr Res; 2017 Jan; 179():50-56. PubMed ID: 27745754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bridging bench and practice: translational research for schizophrenia and other psychotic disorders.
    Wang PS; Heinssen R; Oliveri M; Wagner A; Goodman W
    Neuropsychopharmacology; 2009 Jan; 34(1):204-12. PubMed ID: 18830238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence.
    Morrison AP
    Schizophr Res; 2019 Jan; 203():94-98. PubMed ID: 29606545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.